Based on in vitro results shown in Fig. 2, we expected high TROP2, CD9, and SSEA1 positivity in epithelial cancer cells and the heterogeneous positivity of both epithelial and stromal-like cancer cells for SSEA3, SSEA4, GD2, and Gb3. This evidence concerns the gene TACSTD2 and cancer.